We also demonstrate that USP19 deubiquitinates and rescues both the R241C and R243Q PAH variants from rapid protein degradation, whereas inhibiting USP19, either by sgRNA-mediated knockdown or by broad spectrum DUB inhibitor, promoted the ubiquitination of these two PAH variants. This evidence concerns the gene USP19 and pulmonary arterial hypertension.